Drug Profile
PF 2400013
Alternative Names: PF-02400013; PF-2400013Latest Information Update: 04 Mar 2011
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antipsychotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 28 Feb 2011 Discontinued - Phase-I for Schizophrenia in USA (unspecified route)
- 27 Sep 2010 Phase-I development is ongoing in USA
- 27 Jan 2010 Phase-I clinical trials in Schizophrenia in USA (unspecified route)